Evidence map›Paper›PMID 23308154›Full record

ArticlePloS one2013

Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencing.

Sarah Auburn, Jutta Marfurt, Gareth Maslen, Susana Campino, Valentin Ruano Rubio, Magnus Manske, Barbara Machunter, Enny Kenangalem, Rintis Noviyanti, Leily Trianty and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02610686 (Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02610686 phase4unknown statusnot on this mapstarted 2015, after this paper: background citation

Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam

TypeinterventionalSponsorNational Institute of Malariology, Parasitology and Entomology, VietnamRan2015 to 2016Enrolled100ConditionsPlasmodium VivaxArmsChloroquine
3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Transcriptomics of Plasmodium vivax rosettingMemorias do Instituto Oswaldo Cruz · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Population genomic evidence ofScience advances · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Frontiers in cellular and infection microbiology · 2018
    Review
  11. Malaria Epidemiology at the Clone Level.Trends in parasitology · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A newWellcome open research · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sarah AuburnGlobal and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia. sarah.auburn@menzies.edu.au
Jutta Marfurt
Gareth Maslen
Susana Campino
Valentin Ruano Rubio
Magnus Manske
Barbara Machunter
Enny Kenangalem
Rintis Noviyanti
Leily Trianty
Boni Sebayang
Grennady Wirjanata
Kanlaya Sriprawat
Daniel Alcock
Bronwyn Macinnis
Olivo Miotto
Taane G Clark
Bruce Russell
Nicholas M Anstey
François Nosten
Dominic P Kwiatkowski
Ric N Price

Funding

Medical Research Council G19/9Wellcome Trust 089275Wellcome Trust 090532Wellcome Trust 091625
6 · The paper itself

Abstract

Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical isolates which are generally low in parasitaemia and sample volume. Furthermore, clinical isolates contain a significant contaminating background of host DNA which confounds efforts to map short read sequence of the target P. vivax DNA. Here, we discuss a methodology to significantly improve the success of P. vivax WGS on natural (non-adapted) patient isolates. Using 37 patient isolates from Indonesia, Thailand, and travellers, we assessed the application of CF11-based white blood cell filtration alone and in combination with short term ex vivo schizont maturation. Although CF11 filtration reduced human DNA contamination in 8 Indonesian isolates tested, additional short-term culture increased the P. vivax DNA yield from a median of 0.15 to 6.2 ng µl(-1) packed red blood cells (pRBCs) (p = 0.001) and reduced the human DNA percentage from a median of 33.9% to 6.22% (p = 0.008). Furthermore, post-CF11 and culture samples from Thailand gave a median P. vivax DNA yield of 2.34 ng µl(-1) pRBCs, and 2.65% human DNA. In 22 P. vivax patient isolates prepared with the 2-step method, we demonstrate high depth (median 654X coverage) and breadth (≥89%) of coverage on the Illumina GAII and HiSeq platforms. In contrast to the A+T-rich P. falciparum genome, negligible bias was observed in coverage depth between coding and non-coding regions of the P. vivax genome. This uniform coverage will greatly facilitate the detection of SNPs and copy number variants across the genome, enabling unbiased exploration of the natural diversity in P. vivax populations.

Indexed as

Genome, ProtozoanDNA, ProtozoanHigh-Throughput Nucleotide SequencingHumansMalaria, VivaxPlasmodium vivaxReal-Time Polymerase Chain ReactionDNA, Protozoan

Identifiers

PMID23308154
PMCPMC3537768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.